phorbol-12-myristate has been researched along with cyclin d1 in 1 studies
| Studies (phorbol-12-myristate) | Trials (phorbol-12-myristate) | Recent Studies (post-2010) (phorbol-12-myristate) | Studies (cyclin d1) | Trials (cyclin d1) | Recent Studies (post-2010) (cyclin d1) |
|---|---|---|---|---|---|
| 128 | 0 | 79 | 10,885 | 70 | 5,157 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braga, LE; da Silva, GM; dos Santos, AA; Giestal-de-Araujo, E; Granja, MG | 1 |
1 other study(ies) available for phorbol-12-myristate and cyclin d1
| Article | Year |
|---|---|
PMA increases M3 muscarinic receptor levels and decreases retinal cells proliferation through a change in the levels of cell-cycle regulatory proteins.
Topics: Animals; Cell Proliferation; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Phorbol Esters; Rats; Receptor, Muscarinic M3; Retinal Neurons; Tumor Suppressor Protein p53 | 2013 |